Philip Morris International to Host Webcast of 2025 Second-Quarter and First-Half Results | PM Stock News

Author's Avatar
3 days ago
Article's Main Image
  • Philip Morris International (PM, Financial) will host a live webcast on July 22, 2025, to discuss second-quarter and first-half 2025 financial results.
  • The company's smoke-free products accounted for 42% of its total net revenues in Q1 2025.
  • PMI has invested over $14 billion since 2008 to develop innovative smoke-free products.

Philip Morris International Inc. (PM) is set to host an audio webcast on July 22, 2025, at 9:00 a.m. ET, to discuss the company’s financial performance for the second quarter and the first half of 2025. The results will be released at approximately 7:00 a.m. ET on the same day. The event will be led by Chief Financial Officer Emmanuel Babeau and will feature a Q&A session with the investment community. The webcast can be accessed via PMI’s Investor Relations App on mobile devices.

Emphasizing its commitment to delivering a smoke-free future, PMI reported that its smoke-free products generated 42% of total net revenues during the first quarter of 2025. This achievement aligns with the company’s ongoing efforts to transition its product portfolio away from traditional cigarettes towards innovative smoke-free alternatives, such as heat-not-burn devices, nicotine pouches, and e-vapor products. As of the end of 2024, these products were available in 95 markets and used by an estimated 38.6 million adults worldwide.

To support its smoke-free goal, PMI has invested over $14 billion since 2008 in the development, scientific validation, and commercialization of smoke-free products. These efforts have been bolstered by authorizations from the U.S. Food and Drug Administration, which has granted marketing approval for products like Swedish Match’s General snus, ZYN nicotine pouches, and versions of PMI’s IQOS devices. Furthermore, PMI is poised to expand into wellness and healthcare sectors, leveraging its expertise in life sciences to enhance health experiences globally.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.